These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31857697)

  • 1. TRPV2 channel as a possible drug target for the treatment of heart failure.
    Iwata Y; Ito S; Wakabayashi S; Kitakaze M
    Lab Invest; 2020 Feb; 100(2):207-217. PubMed ID: 31857697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of TRPV2-targeting functional antibody ameliorating dilated cardiomyopathy and muscular dystrophy in animal models.
    Iwata Y; Wakabayashi S; Ito S; Kitakaze M
    Lab Invest; 2020 Feb; 100(2):324-337. PubMed ID: 31896817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of TRPV2 is a Novel Therapy for Cardiomyopathy in Muscular Dystrophy.
    Iwata Y; Matsumura T
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31394715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stretch-activated TRPV2 channels: Role in mediating cardiopathies.
    Aguettaz E; Bois P; Cognard C; Sebille S
    Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):273-280. PubMed ID: 28546113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy.
    Iwata Y; Ohtake H; Suzuki O; Matsuda J; Komamura K; Wakabayashi S
    Cardiovasc Res; 2013 Sep; 99(4):760-8. PubMed ID: 23786999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance.
    Rubinstein J; Lasko VM; Koch SE; Singh VP; Carreira V; Robbins N; Patel AR; Jiang M; Bidwell P; Kranias EG; Jones WK; Lorenz JN
    Am J Physiol Heart Circ Physiol; 2014 Feb; 306(4):H574-84. PubMed ID: 24322617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPV2 channel-based therapies in the cardiovascular field. Molecular underpinnings of clinically relevant therapies.
    O'Connor B; Robbins N; Koch SE; Rubinstein J
    Prog Biophys Mol Biol; 2021 Jan; 159():118-125. PubMed ID: 32565182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of TRPV2 Channel Activation by NK-4, a Cryptocyanine Dye].
    Koya-Miyata S; Kohno K; Morimoto T; Harashima A; Iwata Y; Ariyasu T
    Yakugaku Zasshi; 2022 May; 142(5):535-546. PubMed ID: 35228454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient receptor potential vanilloid 2 function regulates cardiac hypertrophy via stretch-induced activation.
    Koch SE; Mann A; Jones S; Robbins N; Alkhattabi A; Worley MC; Gao X; Lasko-Roiniotis VM; Karani R; Fulford L; Jiang M; Nieman M; Lorenz JN; Rubinstein J
    J Hypertens; 2017 Mar; 35(3):602-611. PubMed ID: 28009703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological and Pathological Role of TRPV1, TRPV2 and TRPV4 Channels in Heart.
    Gorbunov AS; Maslov LN; Jaggi AS; Singh N; De Petrocellis L; Boshchenko AA; Roohbakhsh A; Bezuglov VV; Oeltgen PR
    Curr Cardiol Rev; 2019; 15(4):244-251. PubMed ID: 30848206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probenecid treatment improves outcomes in a novel mouse model of peripartum cardiomyopathy.
    Onusko E; McDermott MR; Robbins N; Liu G; Kranias EG; Rubinstein J; Koch SE
    PLoS One; 2020; 15(3):e0230386. PubMed ID: 32218573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPV2 is critical for the maintenance of cardiac structure and function in mice.
    Katanosaka Y; Iwasaki K; Ujihara Y; Takatsu S; Nishitsuji K; Kanagawa M; Sudo A; Toda T; Katanosaka K; Mohri S; Naruse K
    Nat Commun; 2014 May; 5():3932. PubMed ID: 24874017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation.
    Koch SE; Gao X; Haar L; Jiang M; Lasko VM; Robbins N; Cai W; Brokamp C; Varma P; Tranter M; Liu Y; Ren X; Lorenz JN; Wang HS; Jones WK; Rubinstein J
    J Mol Cell Cardiol; 2012 Jul; 53(1):134-44. PubMed ID: 22561103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dystrophic cardiomyopathy: role of TRPV2 channels in stretch-induced cell damage.
    Lorin C; Vögeli I; Niggli E
    Cardiovasc Res; 2015 Apr; 106(1):153-62. PubMed ID: 25616416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential roles in cardiac physiology and pathology of the cation channel TRPV2 expressed in cardiac cells and cardiac macrophages: a mini-review.
    Entin-Meer M; Keren G
    Am J Physiol Heart Circ Physiol; 2020 Jan; 318(1):H181-H188. PubMed ID: 31809212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Pilot Study of Tranilast for Cardiomyopathy of Muscular Dystrophy.
    Matsumura T; Matsui M; Iwata Y; Asakura M; Saito T; Fujimura H; Sakoda S
    Intern Med; 2018 Feb; 57(3):311-318. PubMed ID: 29093384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPV2 channels mediate insulin secretion induced by cell swelling in mouse pancreatic β-cells.
    Sawatani T; Kaneko YK; Doutsu I; Ogawa A; Ishikawa T
    Am J Physiol Cell Physiol; 2019 Mar; 316(3):C434-C443. PubMed ID: 30649920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-202-5p protects rat against myocardial ischemia reperfusion injury by downregulating the expression of Trpv2 to attenuate the Ca
    Li Y; Li Q; Zhang O; Guan X; Xue Y; Li S; Zhuang X; Zhou B; Miao G
    J Cell Biochem; 2019 Aug; 120(8):13680-13693. PubMed ID: 31062423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of transient receptor potential vanilloid 2 channel in cardiac aging.
    Jones S; Mann A; Worley MC; Fulford L; Hall D; Karani R; Jiang M; Robbins N; Rubinstein J; Koch SE
    Aging Clin Exp Res; 2017 Oct; 29(5):863-873. PubMed ID: 27804106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transient receptor potential vanilloid 2 cation channel is abundant in macrophages accumulating at the peri-infarct zone and may enhance their migration capacity towards injured cardiomyocytes following myocardial infarction.
    Entin-Meer M; Levy R; Goryainov P; Landa N; Barshack I; Avivi C; Semo J; Keren G
    PLoS One; 2014; 9(8):e105055. PubMed ID: 25136832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.